Three things would turn the plan into evidence: a named sale with a price, the next set of results, and a gearing figure on the same definition as the target. Until then, the S$6 billion is a divestment target, not money received.
I scored City Developments’ GET Plus plan against the three conditions that would turn targets into evidence. The shares fell 8% on Monday, but the announcement names divestment pathways, not a single signed transaction with a buyer and price. If you hold SGX property stocks in your CPF or SRS portfolio, this episode explains what to watch before treating the S$6 billion as cash in hand.
Key takeaways:
GET Plus sets S$6b divestments and S$5b new investment over FY2027 to FY2029
No completed sale announced, only a Melbourne JV stake targeted for exit
Dividend payout target of at least 35% of reported profit each year
Net gearing target of about 55% by FY2029, definition attached but starting point unreconciled
Operating profit covered less than 1x the interest bill on prior figures
Iggy’s Forensic Disclaimer
This content is produced for educational and informational purposes only. I am not a financial advisor — I am a retail investor who applies forensic analysis to my own portfolio and shares that process publicly. Nothing here constitutes a recommendation to buy, sell, or hold any security, and no specific target prices or personalised financial advice are offered. Stocks assessed under Iggy’s Forensic Yield Standard are benchmarked against a 4.7% minimum yield hurdle; stocks flagged as Growth Watch fall below this threshold but demonstrate clean balance sheet metrics and an identifiable growth catalyst — these carry a materially different risk profile and are not suitable as yield replacements for income-dependent investors. All data is sourced from public filings and verified sources; where data is unverified it is explicitly flagged. All investments carry risk, including the potential loss of principal, and past performance is not indicative of future results. If you are making investment decisions involving CPF, SRS, or personal capital, please conduct your own due diligence or consult a MAS-licensed financial adviser before committing funds.
